das181
Showing 1 - 10 of 10
Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised Trial in Worldwide (DAS181, Placebo, DAS181 COVID-19)
Recruiting
- Lower Respiratory Tract Infection
- +3 more
- DAS181
- +3 more
-
Duarte, California
- +59 more
Jun 3, 2022
COVID-19 Trial in Milano, Modena (DAS181, Placebo)
Withdrawn
- COVID-19
- DAS181
- Placebo
-
Milano, Italy
- +1 more
Aug 7, 2020
Influenza Infection, SAD-RV Infection and COVID-19 Trial in Shanghai (DAS181, Placebo)
Unknown status
- Influenza Infection
- SAD-RV Infection and COVID-19
- DAS181
- Placebo
-
Shanghai, ChinaRuijin Hospital Affiliated to Shanghai Jiao Tong University Scho
Jul 8, 2020
COVID-19 Trial in Wuhan (DAS181)
Completed
- COVID-19
- DAS181
-
Wuhan, Hubei, ChinaRenmin Hospital of Wuhan University
May 1, 2020
Parainfluenza Infection Trial (DAS181, Placebo)
Withdrawn
- Parainfluenza Infection
- DAS181
- Placebo
- (no location specified)
Dec 14, 2019
Worldwide Trends on COVID-19 Research After Declaration of
Unknown status
- COVID-19
- Convalescent Plasma Transfusion
- +4 more
- (no location specified)
Jul 3, 2020
Influenza Trial in Baltimore (DAS181, Placebo)
Completed
- Influenza
- DAS181
- Placebo
-
Baltimore, MarylandJohns Hopkins Bayview Medical Center - Infectious Diseases
Apr 6, 2017
Influenza Trial in Baltimore (Placebo, DAS181)
Completed
- Influenza
- Placebo
- DAS181
-
Baltimore, MarylandJohns Hopkins Hospital - Medicine - Infectious Diseases
Jul 18, 2013
Influenza Trial in Miramar (DAS181, Placebo)
Completed
- Influenza
- DAS181
- Placebo
-
Miramar, FloridaComprehensive Phase One
Jan 6, 2009